{"version":"1.0","provider_name":"Canadian Drug Policy Coalition","provider_url":"https:\/\/www.drugpolicy.ca\/fr\/","author_name":"admin","author_url":"https:\/\/www.drugpolicy.ca\/fr\/author\/admin\/","title":"Services de consommation supervis\u00e9e et soutien communautaire - Canadian Drug Policy Coalition","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"3WiVfUXvTY\"><a href=\"https:\/\/www.drugpolicy.ca\/fr\/services-de-consommation-supervisee-et-soutien-communautaire\/\">Services de consommation supervis\u00e9e et soutien communautaire<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.drugpolicy.ca\/fr\/services-de-consommation-supervisee-et-soutien-communautaire\/embed\/#?secret=3WiVfUXvTY\" width=\"600\" height=\"338\" title=\"&#8220;Services de consommation supervis\u00e9e et soutien communautaire&#8221; &#8212; Canadian Drug Policy Coalition\" data-secret=\"3WiVfUXvTY\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.drugpolicy.ca\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2012\/11\/CDPC_CommunitySupport_Blog_415x415px-S.jpg","thumbnail_width":415,"thumbnail_height":415,"description":"Les centres d\u2019injection supervis\u00e9e aident \u00e0 sauver des vies et \u00e0 prot\u00e9ger les communaut\u00e9s. Telle fut la conclusion de plus de 30 \u00e9tudes de recherche sur le centre d\u2019injection supervis\u00e9e (CIS) de Vancouver, Insite. Et la Cour supr\u00eame du Canada a exprim\u00e9 son accord en septembre 2011, et ordonn\u00e9 \u00e0 la ministre f\u00e9d\u00e9rale de la [&hellip;]"}